openPR Logo
Press release

Levetiracetam Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

03-01-2023 06:19 AM CET | Health & Medicine

Press release from: Orion Market Research

Levetiracetam Market is Anticipated to Increase at a Stable CAGR

Levetiracetam market is anticipated to grow at a significant CAGR during the forecast period (2023-2029). Levetiracetam is a medication that is sold under the brand name Keppra among others and is used to treat epilepsy. This medicine is used for partial-onset, myoclonic, or tonic-clonic seizures. It is consumed by mouth as an immediate or extended-release formulation or by injecting directly into a vein. The major factor for the growth of the market is the rising prevalence of epilepsy. 

According to the World Health Organization (WHO), in 2019, epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Additionally, almost 80% of people with epilepsy live in low and middle-income countries and up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. However, the risk of mortality is three times higher in people with epilepsy than in the general populace. Hence the rising prevalence of epilepsy is driving the demand for levetiracetam which in turn is boosting the market growth.

Some major key players in the market include Mylan NV, UCB Pharma Ltd., and Novartis International AG (Sandoz Inc.), among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2018, Sandoz Canada announced the launch of Sandoz Levetiracetam 1000 mg to be used as adjunctive therapy to manage patients with epilepsy who are not satisfactorily controlled by conventional therapy.

To Request a Sample of our Report on Levetiracetam Market:  https://www.omrglobal.com/request-sample/levetiracetam-market

Market Coverage

The market number available for - 2022-2029
Base year- 2022
Forecast period- 2023-2029
Segment Covered- 
By Form
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Mylan NV, UCB Pharma Ltd., and Novartis International AG (Sandoz Inc.), among others.

 Levetiracetam Market Report by Segment

By Form

Tablet
Syrup
Injection

By Application 

Myoclonic Treatment
Tonic-clonic Seizures Treatment

A full Report of Levetiracetam Market is Available at:  https://www.omrglobal.com/industry-reports/levetiracetam-market

Levetiracetam Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ea%b2%ac%ec%8b%a4%ed%95%9c-%ed%99%95%ec%9e%a5%ec%9d%84-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-%eb%8d%95%ed%8a%b8%eb%a6%ac%ec%8a%a4-%eb%82%9c%eb%b0%a9-%eb%b0%8f/363339/
https://monblogapple.com/2023/02/27/le-marche-des-trois-roues-electriques-generera-des-revenus-record-dici-2029/
https://www.diario-ya.com/regionales/%e5%88%b0-2029-%e5%b9%b4%ef%bc%8c%e9%a3%9f%e5%93%81%e6%8a%97%e6%b0%a7%e5%8c%96%e5%8a%91%e5%b8%82%e5%a0%b4%e5%b0%87%e5%87%ba%e7%8f%be%e9%a9%9a%e4%ba%ba%e7%9a%84%e5%a2%9e%e9%95%b7/453258/
https://revistaeconomiasocial.com/2023/02/27/el-mercado-de-medicamentos-para-el-sindrome-del-intestino-irritable-con-estrenimiento-sii-c-generara-ingresos-record-para-2029/
https://sportmsr.com/%d8%b3%d9%88%d9%82-%d9%86%d8%b8%d8%a7%d9%85-%d8%a7%d9%84%d9%81%d8%b1%d8%b2-%d9%81%d9%8a-%d8%ac%d9%85%d9%8a%d8%b9-%d8%a3%d9%86%d8%ad%d8%a7%d8%a1-%d8%a7%d9%84%d8%b9%d8%a7%d9%84%d9%85-%d8%aa%d8%ad/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Levetiracetam Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here

News-ID: 2953696 • Views:

More Releases from Orion Market Research

EConsent in Healthcare Market Set to Witness Significant Growth by 2033 | Veeva Systems, eConsent Solutions, Phlexglobal, Mytrus
EConsent in Healthcare Market Set to Witness Significant Growth by 2033 | Veeva …
The EConsent in Healthcare Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.8 billion by 2033, growing at a CAGR of 12.5% from 2025 to 2033. EConsent in Healthcare Market Overview The EConsent in Healthcare Market is witnessing strong growth as healthcare providers increasingly adopt digital consent solutions to streamline patient onboarding, clinical trials, and data-sharing processes. The shift toward electronic health records (EHRs),
Property Management Software (PMS) Market Set to Witness Significant Growth by 2033 | AppFolio, Inc., MSI Solutions, Guestline, Maestro PMS
Property Management Software (PMS) Market Set to Witness Significant Growth by 2 …
The Property Management Software (PMS) Market was valued at USD 4.2 billion in 2024 and is projected to reach USD 10.1 billion by 2033, growing at a CAGR of 10.1% from 2025 to 2033. Property Management Software (PMS) Market Overview The Property Management Software Market is experiencing significant growth as real estate, hospitality, and facility management sectors increasingly adopt digital solutions to streamline operations. PMS enables efficient management of property listings,
Mobile Battery Market Set to Witness Significant Growth by 2033 | Sony Corporation, Toshiba Corporation, ATL (Amp Technology Limited)
Mobile Battery Market Set to Witness Significant Growth by 2033 | Sony Corporati …
The Mobile Battery Market was valued at USD 21.4 billion in 2024 and is projected to reach USD 39.8 billion by 2033, growing at a CAGR of 7.0% from 2025 to 2033. Mobile Battery Market Overview The Mobile Battery Market is witnessing strong growth, driven by the increasing adoption of smartphones, tablets, wearable devices, and other portable electronics. Rising consumer demand for longer battery life, fast charging, and enhanced energy density
DevSecOps Market Set to Witness Significant Growth by 2033 | Checkmarx Ltd., Snyk Ltd., Fortinet Inc., Micro Focus International plc
DevSecOps Market Set to Witness Significant Growth by 2033 | Checkmarx Ltd., Sny …
The DevSecOps Market was valued at USD 5.6 billion in 2024 and is projected to reach USD 17.4 billion by 2033, growing at a CAGR of 12.3% from 2025 to 2033. DevSecOps Market Overview The DevSecOps Market is witnessing significant growth as organizations increasingly integrate security practices into DevOps processes to ensure secure software development. The rising frequency of cyberattacks, stringent regulatory requirements, and growing adoption of cloud-native applications are driving

All 5 Releases


More Releases for Levetiracetam

Levetiracetam Tablets Market Size, Share and Forecast By Key Players-Apeloa Phar …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Levetiracetam Tablets market is anticipated to grow at a compound annual growth rate (CAGR) of 9.92% between 2024 and 2031. The market is expected to grow to USD 20.83 Billion by 2024. The valuation is expected to reach USD 40.37 Billion by 2031. The market for levetiracetam tablets is expanding significantly as a result of the increased incidence of epilepsy and seizures
Workable Strategic Report on Levetiracetam Medicine Market by Forecast to 2030
The key objective of the report is to offer a complete assessment of the Levetiracetam Medicine Market including major leading stakeholders of the Levetiracetam Medicine industry. The current and historical status of the market together with forecasted market size and trends are demonstrated in the assessment in a simple manner. In addition, the report delivers data on the volume, share, revenue, production, and sales in the market. The market report on
Levetiracetam Market Report- Growth with Top Key Vendors like- UCB Pharma, Glaxo …
The research report provides region-wise and country-wise analyses of the Levetiracetam Market. Additionally, Levetiracetam Market provides insights about main regions like Asia-Pacific, Europe, North America, South America, Latin, Middle East, and Africa. Moreover, Levetiracetam Market research report offers in-depth information about lucrative emerging markets and analyzes penetration across the significant market segments. Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5394514 Levetiracetam market is segmented by Type and by Application. Players, stakeholders,
Levetiracetam Market Size, Industry Trends, Share and Forecast 2021-2027
The global levetiracetam market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Levetiracetam is a medication that is sold under the brand name Keppra among others and is used to treat epilepsy. This medicine is used for partial-onset, myoclonic, or tonic-clonic seizures. It is consumed by mouth as an immediate or extended-release formulation or by injecting directly into a vein. The major factor for the
Levetiracetam Market Growth 2021 | Market Trends, Covid-19 Impact, Business Outl …
A number of significant businesses in the market are found in the Levetiracetam Market study. It helps readers comprehend the strategies and partnerships of competitors on the market. A great microscopic survey of the levetiracetam market is provided in the paper. In the ""Levetiracetam Market"" prediction period, readers are able to determine the footprints of manufacturers in terms of their world market sales, manufacturers' global prices, and manufacturers' sales. This research
Epilepsy Drugs Market Growth and Analysis by Key Players 2018: Vimpat(Lacosamide …
A report added to the rich database of Qurate Business Intelligence, titled “Global Epilepsy Drugs Market Size, Status and Forecast 2023”, provides a 360-degree overview of the worldwide market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the data reliable in context